159 related articles for article (PubMed ID: 22380578)
1. Inhibiting citrullination in rheumatoid arthritis: taking fuel from the fire.
Fisher BA; Venables PJ
Arthritis Res Ther; 2012 Feb; 14(1):108. PubMed ID: 22380578
[TBL] [Abstract][Full Text] [Related]
2. Local administration of glucocorticoids decreases synovial citrullination in rheumatoid arthritis.
Makrygiannakis D; Revu S; Engström M; af Klint E; Nicholas AP; Pruijn GJ; Catrina AI
Arthritis Res Ther; 2012 Jan; 14(1):R20. PubMed ID: 22284820
[TBL] [Abstract][Full Text] [Related]
3. Effects of disease-modifying antirheumatic drug treatment on the expression of RANKL and osteoprotegerin in synovial tissue: comment on the article by Haynes et al.
Catrina AI; Klareskog L
Arthritis Rheum; 2008 Nov; 59(11):1685; author reply 1685-6. PubMed ID: 18975354
[No Abstract] [Full Text] [Related]
4. Novel approaches for the treatment of rheumatoid arthritis: lessons from the evaluation of synovial biomarkers in clinical trials.
Gerlag DM; Tak PP
Best Pract Res Clin Rheumatol; 2008 Apr; 22(2):311-23. PubMed ID: 18455687
[TBL] [Abstract][Full Text] [Related]
5. Synovial synoviolin in relation to response to TNF blockade in patients with rheumatoid arthritis and psoriatic arthritis.
Klaasen R; Wijbrandts CA; van Kuijk AW; Pots D; Gerlag DM; Tak PP
Ann Rheum Dis; 2012 Jul; 71(7):1260-1. PubMed ID: 22345123
[No Abstract] [Full Text] [Related]
6. Apoptosis in the rheumatoid arthritis synovial membrane: modulation by disease-modifying anti-rheumatic drug treatment.
Smith MD; Weedon H; Papangelis V; Walker J; Roberts-Thomson PJ; Ahern MJ
Rheumatology (Oxford); 2010 May; 49(5):862-75. PubMed ID: 20147446
[TBL] [Abstract][Full Text] [Related]
7. Antifolate/antiproliferative therapy in rheumatoid arthritis.
Cutolo M
Clin Exp Rheumatol; 2005; 23(4):435-7. PubMed ID: 16095109
[No Abstract] [Full Text] [Related]
8. Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium.
Bramlage CP; Kaps C; Ungethüm U; Bramlage P; Koziolek M; Wessels J; Krenn V; Pruss A; Müller GA; Strutz F; Burmester GR; Häupl T
Scand J Rheumatol; 2008; 37(6):401-9. PubMed ID: 18830904
[TBL] [Abstract][Full Text] [Related]
9. Designing micro- and nano-particles for treating rheumatoid arthritis.
Mitragotri S; Yoo JW
Arch Pharm Res; 2011 Nov; 34(11):1887-97. PubMed ID: 22139688
[TBL] [Abstract][Full Text] [Related]
10. Expanding the citrullinome of synovial fibrinogen from rheumatoid arthritis patients.
Sharma M; Damgaard D; Senolt L; Svensson B; Bay-Jensen AC; Nielsen CH; Hägglund P
J Proteomics; 2019 Sep; 208():103484. PubMed ID: 31408709
[TBL] [Abstract][Full Text] [Related]
11. Effect of biological agents on synovial tissues from patients with rheumatoid arthritis.
Kubota A; Suguro T; Nakajima A; Sonobe M; Tsuchiya K
Mod Rheumatol; 2020 Mar; 30(2):282-286. PubMed ID: 30786801
[No Abstract] [Full Text] [Related]
12. Aggressive strategies for treating aggressive rheumatoid arthritis: has the case been proven?
Furst DE
Lancet; 2000 Jul; 356(9225):183-4. PubMed ID: 10963194
[No Abstract] [Full Text] [Related]
13. Expression and citrullination of keratin in synovial tissue of rheumatoid arthritis.
Chang X; Jian X; Yan X
Rheumatol Int; 2009 Sep; 29(11):1337-42. PubMed ID: 19194706
[TBL] [Abstract][Full Text] [Related]
14. Regulators of cytokine signalling in rheumatoid arthritis.
Rahman A
Rheumatology (Oxford); 2007 Dec; 46(12):1745-6. PubMed ID: 17986480
[No Abstract] [Full Text] [Related]
15. Emerging trends in diagnosis and treatment of rheumatoid arthritis.
Birch JT; Bhattacharya S
Prim Care; 2010 Dec; 37(4):779-92, vii. PubMed ID: 21050958
[TBL] [Abstract][Full Text] [Related]
16. [Glucocorticoids in rheumatoid arthritis: almost always or hardly ever?].
Blanco-Morales EA; Bravo-Ferrer Acosta JM; Rubio Romero E; Gil González E; Gantes Pedraza MÁ
Reumatol Clin; 2011; 7(6):407-11. PubMed ID: 22078702
[TBL] [Abstract][Full Text] [Related]
17. Does treatment with glucocorticoids or with disease-modifying antirheumatic drugs reduce the rate of radiographic progression in rheumatoid arthritis? Comment on the article by Abu-Shakra et al.
Kirwan JR
Arthritis Rheum; 1999 May; 42(5):1066-7. PubMed ID: 10323469
[No Abstract] [Full Text] [Related]
18. Risk of diabetes in patients with rheumatoid arthritis taking hydroxychloroquine.
Di Comite G; Rossi CM
JAMA; 2007 Nov; 298(20):2368-9; author reply 2369-70. PubMed ID: 18042914
[No Abstract] [Full Text] [Related]
19. Inclusion of glucocorticoids in recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: Comment on the article by Saag et al.
van Tuyl LH; Lems WF; Voskuyl AE; Dijkmans BA; Boers M; Kerstens PJ
Arthritis Rheum; 2009 Jan; 61(1):141-2; author reply 141-2. PubMed ID: 19116962
[No Abstract] [Full Text] [Related]
20. MS analysis of rheumatoid arthritic synovial tissue identifies specific citrullination sites on fibrinogen.
Hermansson M; Artemenko K; Ossipova E; Eriksson H; Lengqvist J; Makrygiannakis D; Catrina AI; Nicholas AP; Klareskog L; Savitski M; Zubarev RA; Jakobsson PJ
Proteomics Clin Appl; 2010 May; 4(5):511-8. PubMed ID: 21137068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
